Caprelsa (vandetanib)

pCPA File Number: 20982
Negotiation Status:
Concluded with an LOI
Indication(s):
Medullary Thyroid Cancer
Sponsor/Manufacturer:
Sanofi Genzyme Canada
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: